Fierce Healthcare

FEBRUARY 2, 2022

HHS: Disparities in video telehealth use highlight key barriers to access. rking. Wed, 02/02/2022 - 13:45.

144

144

pharmaphorum

FEBRUARY 1, 2022

A study has shown that a ‘smart’ stethoscope developed by US digital health company Eko can be used to screen people for heart failure in a few second during a standard physical examination. The device tested in the independent study combines a stethoscope used to listen to heart sounds with a single-lead electrocardiogram (ECG). It uses an algorithm to detects low left ventricular ejection fraction (LVEF) – reduced outflow of blood from the heart to the aorta – which is a common cha

Mayo Clinic 140

Mayo Clinic Hospitals FDA 140

Outsourcing Pharma

FEBRUARY 3, 2022

A leader from the artificial intelligence insights specialist talks discusses how the effective use of advanced analytics can lead to a number of benefits.

117

117

Fossil Remedies

FEBRUARY 18, 2022

PCD Pharma Franchise Business. Why are more aspirants willing to make a career in the field of pharmaceuticals? It is because the business is not only promising, but it is going to remain profitable for many years. People have become health conscious and they want to maintain fitness. Also, the recent Covid-19 outbreak has also changed the scenario.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharma Marketing Network

FEBRUARY 10, 2022

Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about engaging oncologists in 2022: 1. Lead with clinical education. It’s no longer enough to build brand awareness, according to the panelists.

Communication 98

Communication 98

Pharma Times

FEBRUARY 24, 2022

No sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial

64

64

pharmaphorum

FEBRUARY 17, 2022

Akili Interactive’s prescription gaming app for attention deficit hyperactivity disorder (ADHD) EndeavorRx has been show to enhance neuronal activity in an area of the brain associated with attention function. The results come from a single-arm, unblinded study of the app, but add to the clinical evidence that EndeavorRx can have a positive impact on children with ADHD which led it to become the prescription game to be approved by the FDA in 2020.

FDA 138

FDA 138

Outsourcing Pharma

FEBRUARY 17, 2022

In its forward-looking report on digital health, the consulting outfit offers predictions on what changes are ahead and how they might impact the field.

115

115

Fuld

FEBRUARY 28, 2022

Competitive Intelligence [CI] has gone through an evolution since becoming a corporate function nearly 4 decades ago. Once viewed as a niche area handled by somebody with the background of a CIA operative, we have seen tremendous growth in businesses adopting and implementing best practices to change how work is done and how intelligence is applied to business issues.

52

52

Roots Analysis

FEBRUARY 28, 2022

Over the past few years, the pharmaceutical industry is growing a tremendous pace. Considering patient’s health and safety, the drug products are expected to be free from microbial contamination and should be safe for use throughout the drug’s life cycle. Therefore, several quality checks are performed to ensure product’s sterility and stability. One of the stages that require quality assurance is packaging of the drug product, as compromised packaging could have serious consequences.

Packaging 52

Packaging Immunization 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

FEBRUARY 18, 2022

New combination treatment can significantly reduce the risk of death among prostate cancer patients

58

58

Fierce Healthcare

FEBRUARY 1, 2022

Unvaccinated 23 times more likely than boosted to be hospitalized during omicron wave. dmuoio. Tue, 02/01/2022 - 16:13.

Hospitals 135

Hospitals 135

pharmaphorum

FEBRUARY 9, 2022

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. According to a report by IQVIA last year, there were 3,500 oncology-focused therapeutic candidates in the pipeline, which represents a 75% increase on figures seen in 2015.

Vaccines 134

Vaccines Immunization Compounding Pharmaceutical Companies 134

Outsourcing Pharma

FEBRUARY 1, 2022

On World Cancer Day, the Union for International Cancer Control is launching a three-year campaign with the goal to improve cancer care around the globe.

112

112

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Marketing Network

FEBRUARY 25, 2022

“ Being more focused, more narrow in terms of the meeting objectives, making sure the right people are there, and making sure that you have quick hit type of interventions during the course of the week to keep track of status is serving us very well. I would suggest that even if and when things return to normal, a lot of those practices and a lot of those mindsets of ways of working will probably continue even after.” – Jeff Fayer, Novartis.

Communication 52

Communication 52

Pharma Mirror

FEBRUARY 25, 2022

Cambridge, UK, Framingham, MA (USA), and Dijon, France, Abzena, a partner research organization for integrated services from discovery through to clinical and commercial manufacturing for biologics and bioconjugates, Alira Health, an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare, and Oncodesign (ALONC -FR0011766229), a biopharmaceutical company dedicated to precision medicine, announce today that, with the launch of DRIVE™-Biologics,

52

52

Pharma Times

FEBRUARY 15, 2022

Francis Crick Institute and King’s College London collaborate to identify specialist cells which protect DNA

Immunization 55

Immunization 55

Fierce Healthcare

FEBRUARY 3, 2022

Meditation app Calm buys Ripple Health Group to build out mental healthcare offerings. rtorrence. Thu, 02/03/2022 - 15:04.

135

135

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

FEBRUARY 21, 2022

Already making inroads as a treatment for HER2-positive breast cancer, AstraZeneca and Daiichi Sankyo’s Enhertu has now shown efficacy in tumours that express lower levels of HER2 – potentially making it an option for a much broader group of patients. It’s a key moment for the two companies, as expansion into HER2-low breast cancer has been held up as a key requirement for Enhertu (trastuzumab deruxtecan) if it is to achieve its multibillion-dollar sales expectations.

Chemotherapy 132

Chemotherapy Labelling 132

Outsourcing Pharma

FEBRUARY 7, 2022

The HIV-focused pharma company announced the agency has approved Cabenuva for administration as few as six times a year for adults living with the virus.

FDA 109

FDA 109

Roots Analysis

FEBRUARY 24, 2022

Since the approval of the first antisense therapy in 1998, oligonucleotides have been in light for their capabilities as therapeutic agents. Oligonucleotides are short synthetic nucleotide chains with immense potential in the diagnosis and treatment of a myriad of disease indications. In addition to therapeutics, these complex molecules act as a significant resource in various research applications.

52

52

Pharma Mirror

FEBRUARY 24, 2022

Taking care of your mental health can be affordable. All you will have to do is choose therapy options that fit in your budget. In this article, we have outlined the most affordable therapy options. While the options fall in the lower price range, they are all capable of delivering your expected results. The post Ways to Access Affordable Mental Health Services appeared first on Pharma Mirror Magazine.

52

52

Pharma Times

FEBRUARY 22, 2022

The European Commission finds that Servier committed a breach of competition over blood pressure drug

54

54

Fierce Healthcare

FEBRUARY 1, 2022

Kindbody hits unicorn status with Vios Fertility Institute acquisition, new leadership additions. rtorrence. Tue, 02/01/2022 - 17:13.

130

130

pharmaphorum

FEBRUARY 18, 2022

The pandemic-induced transition to digital health is, according to the Nuffield Trust, contributing to an “inverse care law” that’s compounding existing health inequalities. But, as demonstrated by initiatives like the Telehealth Equity Coalition (TEC), the sector is taking a united stand against inequitable access. Technological solutions, from online clinics to app-based long-term condition management, have long been hailed as a solution to problems such as limited capacity and low patient aut

Compounding 132

Compounding 132

Outsourcing Pharma

FEBRUARY 9, 2022

The companyâs analysis of trials conducted around the world last year shows cancers took four of the top five positions, with COVID-19 in second place.

105

105

Roots Analysis

FEBRUARY 23, 2022

NGS has emerged as an evolutionary technology in modern biotechnology and healthcare research, enabling researchers to develop a better understanding of the cause and consequences of disease. Over the past few years, several companies have started offering a diverse range of genome sequencing products and services using various second and third generation sequencing technologies.

Immunization 52

Immunization 52

Pharma Mirror

FEBRUARY 24, 2022

Hoboken, NJ, Rostock/Berlin, Germany, Based on Whole Genome Sequencing (WGS), Arcensus GmbH makes it possible to detect rare as well as frequent disorders such as cancer or heart diseases at the earliest stage in order to start preventive and personalized treatment. One year after Arcensus was founded, fresh capital is now being raised for further expansion.

52

52

Pharma Marketing Network

FEBRUARY 18, 2022

Join PMN and industry experts from Novo Nordisk, Esai, GSK, Otsuka and more for part 1 of a 2 part series on engagement. The PMN HCP Engagement Summit , 03/02/2022 @ 12PM EST, will focus on HCP Engagement on the following panel topics: Modular Content: Making It Work. Get insights for pharma marketing insiders on restructuring you content strategy allowing more flexibility and agility to deliver more relative content to your customers.

52

52

Fierce Healthcare

FEBRUARY 3, 2022

Butterfly Network, Ambra Health team up to streamline medical imaging integration. agliadkovskaya. Thu, 02/03/2022 - 16:18.

124

124

pharmaphorum

FEBRUARY 1, 2022

Telehealth came to the fore in in 2020 and 2021 as healthcare systems struggled to deal with the consequences of the pandemic, but the coming year could see big changes to the sector after a period of breakneck growth. A new report from Boston Consulting Group’s Digital Ventures team predicts that with the category becoming increasingly crowded there will be consolidation as the early movers try to stay ahead of upstart competition – as already seen with 2020’s $18.5 billion merger b

Health and Personal Care Stores 131

Health and Personal Care Stores Vaccines 131

Outsourcing Pharma

FEBRUARY 8, 2022

The latest in the Diversity in Oncology series, taking place February 9, will discuss ways academia and community collaboration can narrow representation gaps.

103

103

Roots Analysis

FEBRUARY 22, 2022

With the increasing global population, the incidence rates of several chronic disease indications, such as diabetes, anaphylaxis, rheumatoid arthritis and psoriasis, are on the rise. This has led to a rise in the demand for effective treatment options for patients suffering from these diseases. Further, in order to improve the quality of life in these patients, companies have developed novel devices capable of delivering a variety of formulations of different drugs / therapies, in an efficient a

Dosage 52

Dosage Immunization FDA 52